FDA and CMS: A Path for Parallel Approvals for Innovative Technologies
01 April 2012
Medical Design
Publication
Author(s):
Judith A. Waltz
Medical Design
Partner Judith Waltz authored an article that appeared in Medical Design on April 1, 2012 titled "FDA and CMS: A path for parallel approvals for innovative technologies."
Click here to read the complete article.
Click here to read the complete article.
Author(s)
Related Services
Sectors
Insights
‘Move fast and break things’ is a bad idea for health tech startups
18 May 2022
Health Care Law Today
Foley Automotive Report
17 May 2022
Dashboard Insights
Episode 21: Putting People First in Behavioral Health Reform
17 May 2022
Health Care Law Today
Watch The Fine Print: Ninth Circuit Majority Opinion Requires Heightened Standards for Reasonably Conspicuous Notice of Browsewrap Terms to Compel Arbitration
16 May 2022
Consumer Class Defense Counsel
Foley Sponsors Ernst & Young Entrepreneur of the Year® Program
1 December 2021 - 30 November 2022
Michigan and Northwest Ohio Region
U.S.-India Chamber of Commerce Annual Technology Conference 2022
26 May 2022
Dallas, TX
Venture Debt in Latin America
24 May 2022
Webinar
Words Matter: Crafting Arbitration Agreements That Stick — A View from the Trenches
19 May 2022
Webinar